Public Reporting

Overview


ACO Name and Location

MD Valuecare, LLC
1021 East Cary Street, Suite 1400
Richmond, VA – 23219

ACO Primary Contact

Tiffany Lange, ACO Administrator
1021 East Cary Street, Suite 1400
Richmond, VA – 23219
(804) 512-3017
LangeConsulting@verizon.net

Organizational Information

ACO Participants

“(ACO participants are not in a joint venture)”
Chickahominy Family Practice

Commonwealth Primary Care

Dominion Medical Associates

Virginia Diabetes and Endocrinology

ACO Participants in Joint Ventures Between ACO Professionals and Hospitals

None.

ACO Governing Body

Dr. John Kowalski

Dr. Damian Covington

Dr. Paul McTamaney

Voting Member (11.11%), Medicare Beneficiary Representative

Dr. Dave Taminger

Dr. Steve Young

Dr. Ken Zelenak

Dr. Shea Bethea

Voting Member (11.11%), ACO Participant Representative, Virginia Diabetes and Endocrinology

Key Clinical and Administrative Leadership

ACO Executive

Dr. Ken Zelenak

Medical Director

Ms. Tiffany Lange

Compliance Official

Dr. Stephen Cavalieri

Quality Assurance / Improvement Officer

ACO Committees and Committee Leadership

Quality Committee: Dr. Ken Zelenak, Chair

Managing Committee: Katie Nunn, Chair

Specialist Mobilization Committee: Dr. Mark Monahan, Co-Chair and Dr. Johnny Wong, Co-Chair

Types of ACO Participants, or Combinations of Participants, that Formed the ACO

Network of individual practices of ACO professionals.


Shared Savings and Losses

Amount of Shared Savings and Losses

First Agreement Period

  • Performance Year 2016, $1,809,663
  • Performance Year 2015, $0
  • Performance Year 2014, $0

How Shared Savings Are Distributed

Proportion invested in infrastructure: Not yet determined

Invested in redesigned care processes/resources: Not yet determined

Proportion of distribution to ACO participants: Not yet determined

Payment Rule Waivers: No, our ACO does not use the SNF 3-Day Rule Waiver.


Quality Performance Results

  
2016 Reporting Period
ACO#Measure NameACO Performance Rate (%)Mean Performance Rate (SSP ACOs) (%)
ACO-1CAHPS: Getting Timely Care, Appointments, and Information 80.9579.9
ACO-2CAHPS: How Well Your Providers Communicate 93.692.63
ACO-3CAHPS: Patients’ Rating of Provider 93.1391.93
ACO-4CAHPS: Access to Specialists 82.2483.52
ACO-5CAHPS: Health Promotion and Education62.8460
ACO-6CAHPS: Shared Decision Making 77.2575.28
ACO-7CAHPS: Health Status/Functional Status 73.371.82
ACO-34CAHPS: Stewardship of Patient Resources*32.6627.52
ACO-8Risk Standardized, All Condition Readmission13.914.7
ACO-35Skilled Nursing Facility 30-day All-Cause Readmission measure (SNFRM)* Readmission17.1618.17
ACO-36All-Cause Unplanned Admissions for Patients with Diabetes*42.9153.2
ACO-37All-Cause Unplanned Admissions for Patients with Heart Failure*60.7575.23
ACO-38All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions49.3559.81
ACO-9Ambulatory Sensitive Condition Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5)7.939.27
ACO-10Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8)13.5614.53
ACO-11Percent of PCPs who Successfully Meet Meaningful Use Requirements98.1182.72
ACO-39Documentation of Current Medications in the Medical Record97.6187.54
ACO-13Falls: Screening for Future Fall Risk 87.164.04
ACO-14Preventive Care and Screening: Influenza Immunization87.2868.32
ACO-15Pneumonia Vaccination Status for Older Adults85.5769.21
ACO-16Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up77.5174.45
ACO-17Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention96.8590.98
ACO-18Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan76.2453.63
ACO-19Colorectal Cancer Screening69.7761.52
ACO-20Breast Cancer Screening74.867.61
ACO-21Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented 90.1976.84
ACO-42Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
79.3377.72
ACO-27Diabetes Mellitus: Hemoglobin A1c Poor Control 9.318.24
ACO-41Diabetes: Eye Exam*72.1144.94
ACO-28Hypertension: Controlling High Blood Pressure 7370.52
ACO-30Ischemic Vascular Disease: Use of Aspirin or Another Antithrombotic91.9885.05
ACO-31Heart Failure: Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)83.4788.67
ACO-33Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%)77.0479.67
CAHPS = Consumer Assessment of Healthcare Providers and Systems, PQI = Prevention Quality Indicator, LVSD = left ventricular systolic dysfunction, ACE = angiotensin-converting enzyme, ARB = angiotensin receptor blocker, CAD = coronary artery disease.
*= Measure required beginning Reporting Year 2015.
N/A = Reporting on the depression remission measure is not required for 2015, as indicated by N/A.
Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples.

Note: In the Quality Performance Results file(s) above, search for “MD Valuecare, LLC” or “MD Value Care” to view the quality performance results. This ACO can also be found by using the ACO ID A39151 in the public use files on data.cms.gov.

14600+
Patients
430+
Providers
34
Quality
Measures